Early transition from insulin to sulfonylureas in neonatal diabetes and follow ‐up: Experience from China

ConclusionsMolecular genetic diagnosis is recommended in all patients with NDM. However, if genetic testing results are delayed, sulfonylurea therapy should be considered before such results are received, even in infants with newly diagnosed NDM.

Source: Pediatric Diabetes - August 9, 2017 Category: Endocrinology Authors: Xiuzhen Li, Aijing Xu, Huiying Sheng, Tzer Hwu Ting, Xiaojian Mao, Xinjiang Huang, Minyan Jiang, Jing Cheng, Li Liu Tags: ORIGINAL ARTICLE Source Type: research